Allegheny Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$901K	Buy	2,018 +15	+0.7%	+$6.99K	0.12%	110
2025 Q4	$908K	Sell	2,003 -6	-0.3%	-$2.59K	0.13%	108
2025 Q3	$787K	Buy	2,009 +9	+0.5%	+$3.76K	0.15%	113
2025 Q2	$890K	Hold	2,000	–	–	0.2%	100
2025 Q1	$970K	Sell	2,000 -19	-0.9%	-$8.85K	0.25%	77
2024 Q4	$813K	Sell	2,019 -21	-1%	-$9.73K	0.21%	90
2024 Q3	$949K	Buy	2,040 +19	+0.9%	+$9.13K	0.23%	80
2024 Q2	$947K	Sell	2,021 -240	-11%	-$104K	0.27%	70
2024 Q1	$945K	Sell	2,261 -66	-3%	-$27.9K	0.29%	66
2023 Q4	$947K	Buy	2,327 +21	+0.9%	+$7.76K	0.3%	62
2023 Q3	$802K	Buy	2,306 +306	+15%	+$107K	0.3%	62
2023 Q2	$704K	Hold	2,000	–	–	0.33%	56
2023 Q1	$630K	Hold	2,000	–	–	0.25%	78
2022 Q4	$578K	Hold	2,000	–	–	0.24%	85
2022 Q3	$579K	Hold	2,000	–	–	0.27%	72
2022 Q2	$564K	Hold	2,000	–	–	0.26%	75
2022 Q1	$522K	Hold	2,000	–	–	0.22%	78
2021 Q4	$439K	Buy	+2,000	New	+$389K	0.18%	85